,ACAT2

Yanfeng Liu1,2,3, Feng Ding4, Liangying Deng1

  • 1Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

概括

研究人员通过虚拟查工作流程确定了针对Acy-CoA:胆固醇乙烯转移酶2 (ACAT2) 的新型抑制剂. 这些化合物有望通过选择性抑制ACAT2.2,治疗高胆固醇和动脉样硬化.